Please login to the form below

Not currently logged in
Email:
Password:

Digitas appoints Michael Leis

Move backs up its social strategy drive

Michael LeisDigitas Health has made a new senior hire that it hopes will help push social media to the centre of its clients' brand strategies.

Michael Leis, newly appointed senior vice president of social strategy, will focus on helping clients move social strategy to the heart of their brand strategy, the agency said.

Leis joins Digitas Health from Draft/FCB in Chicago, where he led social strategy for clients including Taco Bell, Discover Card, Cox Communications and Sony.

He will report to SVP of emerging channels and technology Brendan Gallagher, who oversees the mobile and UX capabilities for Digitas Health.

“I joined Digitas Health because they are at the forefront of the customer centric transformation taking place in healthcare marketing,” says Leis. “There is no better time or place for social strategy innovation healthcare.”

Based at Digitas Health's Philadelphia headquarters, Lies will also support client social strategies across the Digitas Health network, including the London and New York businesses.

“Michael is one of those left brained-right brained people who brings strategic rigor and a love of 'what if?' to his work,” said Alexandra von Plato, president and global chief creative officer at Digitas' parent company Publicis Healthcare Communications Group.  

“While social media and customer centricity are hot topics, most of our clients are still treating social as a novelty rather than a core part of brand strategy. Michael will help change that.”

19th December 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics